Education

Georgetown University Law Center, J.D. (1998)
       Member, Journal of Legal Ethics
The University of Chicago, Ph.D. in Chemistry (1992)
The College of William and Mary, B.S. in Chemistry (With High Honors, 1986)

Experience

Paul A. Braier joined the firm in 1995. Prior to joining the firm and earning his law degree, Dr. Braier earned a Ph.D. in Chemistry at the University of Chicago and then worked as a Lady Davis postdoctoral fellow at Hebrew University.

Practice Areas

Dr. Braier is a supervisor in the client counseling, licensing and technology transfer practice group. His work in this group involves preparing and supervising preparation of infringement and validity opinions, as well as counseling clients, particularly in the pharmaceutical, chemical, and medical arts. Dr. Braier is involved extensively in the firm's pharmaceutical practice and advises generic and branded drug companies on strategic planning and new product introduction. In this regard, he works extensively with Hatch-Waxman issues and the interface of patent and FDA law.

Dr. Braier also prepares and prosecutes patent applications in the pharmaceutical and chemical arts as an attorney in the patent procurement practice group. He has prepared and prosecuted patent applications in areas including pharmaceutical dosage forms and methods of use, polymer synthesis, papermaking technology, textiles, semiconductors, medical devices, and others.

Dr. Braier is a panelist in an annual seminar given in association with the annual conferences of the International Generic Pharmaceutical Association. He has also spoken at other public events, including the United States Pharmacopeia and CBI's Generic Drugs Forums on intellectual property issues regarding generic drugs.

Admissions

1997, U.S. Patent and Trademark Office
1999, Virginia

Courts

Supreme Court of Virginia

Representative Publications

Braier, Paul. (June 2005). The ABC's of ANDAs: A primer on the generic drug approval process in the United States. PharmaChem, 8-11.

Braier, Paul. (April 2004). New Medicare law brings changes to Hatch-Waxman Act. J. Generic Medicines, 1(3), 267-272.

Braier, Paul. (in press). U.S. case law developments in the U.S. J. Generic Medicines, 3(3).